Upon Covid-19 vaccine’s.
Lyon, France, April 25th, 2023 – CYNBIOSE, a service company specializing in the
development of innovative preclinical models, in partnership with VIRNEXT, a technological
platform specializing in respiratory infectious diseases and evaluation of prophylactic and
therapeutic treatments, have contributed actively to the preclinical assessment and
accelerated transfer to clinical trial of HIPRA’s Covid-19 vaccine.